Retrospective Multicenter Study on Clinical Aspects in Premature Ovarian Failure.
10.6118/jksm.2011.17.3.160
- Author:
Ji Su HUH
1
;
Seok Kyo SEO
;
Mee Ran KIM
;
Hye Won CHUNG
;
Byung Koo YOON
;
Byung Seok LEE
;
Byung Moon KANG
;
Hoon CHOI
;
Hyung Moo PARK
;
Jung Gu KIM
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Yonsei University, Seoul, Korea. dr222@yuhs.ac
- Publication Type:Multicenter Study ; Original Article
- Keywords:
Premature ovarian failure;
Primary amenorrhea;
Secondary amenorrhea
- MeSH:
Amenorrhea;
Bone Density;
Clomiphene;
Estradiol;
Estrogens;
Female;
Gonadotropins;
Humans;
Oocyte Donation;
Osteoporosis;
Pregnancy;
Pregnancy Rate;
Prevalence;
Primary Ovarian Insufficiency;
Retrospective Studies
- From:The Journal of Korean Society of Menopause
2011;17(3):160-165
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Premature ovarian failure (POF) is a syndrome defined as the cessation of ovarian function before the age of 40 years that is characterized by amenorrhoea associated with elevated gonadotropin levels. The aim of this study was to compare clinical manifestation of primary amenorrhea and secondary amenorrhea group. METHODS: This study was designed as a retrospective multicenter study of 262 women with premature ovarian failure. Sixty eight women with primary amenorrhea and 194 women with secondary amenorrhea were evaluated and hormonal level, lipid profile, bone mineral density, and pregnancy rates were compared. RESULTS: The estradiol level was markedly lower in primary amenorrhea than secondary amenorrhea. The pregnancy rate of 43.3% before the diagnosis in secondary amenorrhea was markedly higher than the rate of 0% in primary amenorrhea. The pregnancy rates after treatment was 5.9% in primary amenorrhea, but 1.0% after diagnosis and 2.8% after treatment in secondary amenorrhea. The pregnancy rate after hormonal treatment was 3.7% in total, 8.3% in primary amenorrhea, and 2.8% in secondary amenorrhea. In nine cases of pregnancy, seven cases were after estrogen-progestin (EP), one case was after clomiphene citrate and one case was after EP/human menopausal gonodotropin (hMG). And In nine cases of pregnancy, six cases resulted from oocyte donation. The prevalence of osteopenia/osteoporosis was markedly higher in primary amenorrhea than in secondary amenorrhea. CONCLUSION: Premature ovarian failure has negative influences on the physical and psychological health of young patients. Effective management should include earlier diagnosis and intensive medical intervention to relieve symptoms of estrogen deficiency and to treat long-term disease such as osteoporosis and in assisted pregnancy by oocyte donation.
